Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a

Anadolu, R; Oskay, T; Erdem, C; BOYVAT, AYŞE; Terzi, E; Gurgey, E

doi:10.1067/mjd.2001.114575

Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a

Anadolu R., Oskay T., Erdem C., BOYVAT A., Terzi E., Gurgey E.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, cilt.45, sa.2, ss.296-299, 2001 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 2
Basım Tarihi: 2001
Doi Numarası: 10.1067/mjd.2001.114575
Dergi Adı: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.296-299
Ankara Üniversitesi Adresli: Evet

Özet

Epidermodysplasia verruciformis (EV) is an autosomal recessive disease characterized by the lifelong eruption of disseminated verrucae-like lesions. Numerous treatment modalities have been used to treat EV without benefit. Recently, retinoid and interferon therapies have been found to be of value in the treatment of EV We present a case of EV that was treated with a combination of acitretin and interferon alfa-2a.